Evidence map›Paper›PMID 42433548›Full record

ArticleQuantitative imaging in medicine and surgery2026

Fine-tuned multimodal GPT-4o for generating diagnostic impressions in breast magnetic resonance imaging: insights into non-mass enhancement lesions.

Jiahuan Tang, Xiaoqing Yu, Di Kang, Shengqin Luo, Meihong Sheng

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiahuan TangDepartment of Radiology, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, China.ORCID https://orcid.org/0009-0003-5862-7420
Xiaoqing YuDepartment of Radiology, Nantong First People's Hospital, Southeast University, Affiliated Nantong Clinical College of Nantong University, Nantong, China.ORCID https://orcid.org/0009-0008-1265-9001
Di KangDepartment of Radiology, Nantong First People's Hospital, Southeast University, Affiliated Nantong Clinical College of Nantong University, Nantong, China.ORCID https://orcid.org/0009-0008-6667-4901
Shengqin LuoNanhu Laboratory, Jiaxing, China.ORCID https://orcid.org/0009-0008-5939-6616
Meihong ShengDepartment of Radiology, Nantong First People's Hospital, Southeast University, Affiliated Nantong Clinical College of Nantong University, Nantong, China.ORCID https://orcid.org/0000-0002-7927-8886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have reported limited performance of publicly available large language models for Breast Imaging Reporting and Data System (BI-RADS) categorization of breast lesions. However, their application to breast non-mass enhancement (NME) lesions has not been specifically investigated. This study evaluated the diagnostic capability of multimodally fine-tuned ChatGPT-4 omni [generative pre-trained transformer 4 omni (GPT-4o)] for breast NME lesions, focusing on the accuracy of generated diagnostic impressions. Methods: In this retrospective study, magnetic resonance imaging (MRI) contrast-enhanced images, radiology reports, and clinical histories of 229 patients with breast NME lesions were collected. Six models were developed across three settings: zero-shot without fine-tuning (A1 and A2), single-modality fine-tuning (B and C), and multimodal fine-tuning (D and E). The models were evaluated for their ability to generate summarized imaging reports. Their diagnostic performance was compared against that of three radiologists with varying experience levels. Finally, the models were comprehensively assessed by the three additional experts using a five-point Likert scale. Results: The zero-shot models achieved area under the receiver operating characteristic curve (AUC) of 0.67-0.68, slightly outperforming junior radiologists but remaining inferior to experienced radiologists. Among the fine-tuned models, the image-only model (Model B) showed the poorest performance [AUC, 0.56; 95% confidence interval (CI): 0.45-0.66], significantly inferior to the other models (all P≤0.047). In contrast, the text-only and multimodal fine-tuned models showed substantial performance improvements. Model E achieved the best performance, with an AUC of 0.81 (95% CI: 0.74-0.89), significantly outperforming the zero-shot, image-only, and text-only models (all P≤0.039). Model E also outperformed junior radiologists (P<0.001), while showing no significant difference compared with intermediate and senior radiologists (P=0.060 and 0.367, respectively). The average expert evaluation score for Model E was 4.94/5. Compared with senior radiologists, specificity increased by 14.0%, whereas sensitivity decreased by 5.3%. Agreement for model-generated BI-RADS assessments was moderate both within the model outputs (κ=0.47) and between the model and senior radiologists (κ=0.49). Conclusions: Multimodally fine-tuned GPT-4o can generate clinically accurate diagnostic impressions for complex breast NME lesions with performance approaching that of experienced radiologists. The model can improve diagnostic specificity and may serve as a useful second reader for breast MRI interpretation, particularly for less experienced radiologists, although expert supervision remains necessary because sensitivity was slightly lower than that of senior radiologists.

Indexed as

breastfine-tuningmagnetic resonance imaging (MRI)Multimodal generative pre-trained transformer 4 omni (multimodal GPT-4o)non-mass enhancement (NME)

Identifiers

PMID42433548
PMCPMC13349979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.